Company Description
HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence.
It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-native vendor- and device-agnostic ECG management platform.
The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024.
HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.
| Country | United States |
| Founded | 2007 |
| IPO Date | Jun 15, 2022 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 14 |
| CEO | Andrew Simpson |
Contact Details
Address: 550 Reserve Street, Suite 360 Southlake, Texas 76092 United States | |
| Phone | 682 237 7781 |
| Website | heartsciences.com |
Stock Details
| Ticker Symbol | HSCS |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | May - April |
| Reporting Currency | USD |
| IPO Price | $4.25 |
| CIK Code | 1468492 |
| CUSIP Number | 42254E302 |
| ISIN Number | US42254E3027 |
| Employer ID | 26-1344466 |
| SIC Code | 6199 |
Key Executives
| Name | Position |
|---|---|
| Andrew Simpson | Chief Executive Officer, President and Chairman of the Board of Directors |
| Danielle Watson | Chief Financial Officer and Treasurer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 20, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Aug 20, 2026 | 8-K | Current Report |
| Aug 19, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Aug 19, 2026 | 8-K/A | [Amend] Current report |
| Aug 19, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Aug 19, 2026 | 8-K | Current Report |
| Aug 18, 2026 | SCHEDULE 13D | Filing |
| Aug 18, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Aug 18, 2026 | 8-K | Current Report |
| Aug 7, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |